Articles related to ANTITHROMBOTIC THERAPY
What are the Management Considerations for Venous Thromboembolic Events in Patients with Cirrhosis?
For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.
Gastroenterology February 22nd 2024
Management of Venous Thromboembolism in Patients with Active Cancer (CME)
Venous thromboembolism presents a significant challenge in cancer care, with emerging evidence supporting the use of direct oral anticoagulants for improved outcomes. This highlights the evolving landscape of VTE management in oncology, stressing the importance of personalized treatment strategies.
Hematology/Oncology February 20th 2024
Anticoagulation Management of Post-cardiac Surgery New-onset Atrial Fibrillation
In the complex landscape of post-cardiac surgery care, the incidence of new-onset PCSAF presents a significant challenge, necessitating a judicious approach to anticoagulation to prevent thromboembolic events while minimizing bleeding risks.
Cardiology February 14th 2024
Anticoagulants Fail to Prevent Unexplained Strokes, Clinical Trial Finds
This study underscores the critical need for precise diagnostic criteria in treating unexplained strokes and the potential reevaluation of anticoagulant use in patients with atrial cardiopathy, opening new avenues for research and patient care.
Neurology February 13th 2024
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke
The study underscores the potential of dual antiplatelet therapy in reducing the risk of recurrent stroke. However, it also highlights the need for careful patient selection due to the slightly increased risk of moderate-to-severe bleeding.
Neurology January 3rd 2024